drugset / Trial / NCT00044044
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of the drug SM-13496 compared to a placebo and to haloperidol in patients with schizophrenia.
Timeline
- Start
- 2002-07
- Primary completion
- 2003-05
- Completion
- 2003-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Haloperidol | Other / unclassified | 10 mg | — |
| Subject | Lurasidone | Small molecule | 20 mg | — |
| Subject | Lurasidone | Small molecule | 40 mg | — |
| Subject | Lurasidone | Small molecule | 80 mg | — |